These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22808258)

  • 21. Paxillin promotes tumor progression and predicts survival and relapse in oral cavity squamous cell carcinoma by microRNA-218 targeting.
    Wu DW; Chuang CY; Lin WL; Sung WW; Cheng YW; Lee H
    Carcinogenesis; 2014 Aug; 35(8):1823-9. PubMed ID: 24894864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview.
    Krüger M; Pabst AM; Walter C; Sagheb K; Günther C; Blatt S; Weise K; Al-Nawas B; Ziebart T
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1506-14. PubMed ID: 24947612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of TP53 mutations in oral squamous cell carcinoma with human papilloma virus infection.
    Kozomara RJ; Brankovic-Magic MV; Jovic NR; Stosic SM; Magic ZM
    Int J Biol Markers; 2007; 22(4):252-7. PubMed ID: 18161655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Priority of fibular reconstruction in patients with oral cavity cancer undergoing segmental mandibulectomy.
    Lin CH; Kang CJ; Tsao CK; Wallace CG; Lee LY; Lin CY; Wang HM; Ng SH; Yen TC; Liao CT
    PLoS One; 2014; 9(4):e94315. PubMed ID: 24722353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control.
    Ishibashi M; Kishino M; Sato S; Morii E; Ogawa Y; Aozasa K; Kogo M; Toyosawa S
    Int J Clin Oncol; 2011 Dec; 16(6):646-53. PubMed ID: 21528380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
    Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
    Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
    Gröbe A; Hanken H; Kluwe L; Schöllchen M; Tribius S; Pohlenz P; Clauditz T; Grob T; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2013 Oct; 42(9):676-81. PubMed ID: 23721566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery.
    Dong L; Xue L; Cheng W; Tang J; Ran J; Li Y
    BMC Oral Health; 2024 Aug; 24(1):919. PubMed ID: 39123139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
    Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
    Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas.
    Chuang CY; Sung WW; Wang L; Lin WL; Yeh KT; Su MC; Hsin CH; Lee SY; Wu BC; Cheng YW; Lee H
    PLoS One; 2012; 7(10):e47541. PubMed ID: 23118878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
    Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
    Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of human papillomavirus in oral squamous cell carcinoma (review).
    Gogilashvili K; Shonia N; Burkadze G
    Georgian Med News; 2012 Dec; (213):32-6. PubMed ID: 23293230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation.
    Lohavanichbutr P; Méndez E; Holsinger FC; Rue TC; Zhang Y; Houck J; Upton MP; Futran N; Schwartz SM; Wang P; Chen C
    Clin Cancer Res; 2013 Mar; 19(5):1197-203. PubMed ID: 23319825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer?
    Sritippho T; Pongsiriwet S; Lertprasertsuke N; Buddhachat K; Sastraruji T; Iamaroon A
    Asian Pac J Cancer Prev; 2016; 17(8):4049-57. PubMed ID: 27644660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.